Immunovant, Inc. (IMVT) Misses Q3 EPS by 10c

Immunovant, Inc. (NASDAQ: IMVT) reported Q3 EPS of ($0.49), $0.10 worse than the analyst estimate of ($0.39).

For earnings history and earnings-related data on Immunovant, Inc. (IMVT) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Lumentum shares rise on analyst upgrades, AI demand outlook
• Circle Internet stock climbs on TD Cowen upgrade, Fed rate hike